We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+5.09%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$29.2B
AUM Growth
+$1.4B
Cap. Flow
+$144M
Cap. Flow %
0.49%
Top 10 Hldgs %
23.08%
Holding
3,780
New
179
Increased
1,287
Reduced
1,288
Closed
176

Sector Composition

Rank Sector Weight
1 Industrials 12.17%
2 Financials 11.31%
3 Healthcare 10.5%
4 Technology 9.1%
5 Consumer Staples 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFLN
3251
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$305M
$4K ﹤0.01%
229
-270
-54% -$5.08K
PPA icon
3252
Invesco Aerospace & Defense ETF
PPA
$8.27B
$4K ﹤0.01%
102
-128
-56% -$5.53K
PWB icon
3253
Invesco Large Cap Growth ETF
PWB
$2.29B
$4K ﹤0.01%
120
QQXT icon
3254
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$152M
$4K ﹤0.01%
100
RMBS icon
3255
Rambus
RMBS
$10.4B
$4K ﹤0.01%
303
SCO icon
3256
ProShares UltraShort Bloomberg Crude Oil
SCO
$585M
$4K ﹤0.01%
+1
New +$2.78K
HTO
3257
H2O America
HTO
$2.67B
$4K ﹤0.01%
77
-26
-25% -$1.28K
SNEX icon
3258
StoneX
SNEX
$8.83B
$4K ﹤0.01%
496
STRA icon
3259
Strategic Education
STRA
$1.71B
$4K ﹤0.01%
44
SWZ
3260
Swiss Helvetia Fund
SWZ
$76.3M
$4K ﹤0.01%
350
TG icon
3261
Tredegar Corp
TG
$268M
$4K ﹤0.01%
+222
New +$4.63K
TRC icon
3262
Tejon Ranch
TRC
$476M
$4K ﹤0.01%
+177
New +$4K
VKI icon
3263
Invesco Advantage Municipal Income Trust II
VKI
$394M
$4K ﹤0.01%
+353
New +$3.95K
VNDA icon
3264
Vanda Pharmaceuticals
VNDA
$312M
$4K ﹤0.01%
+300
New +$4.28K
VRTS icon
3265
Virtus Investment Partners
VRTS
$1.11B
$4K ﹤0.01%
35
-50
-59% -$5.59K
WD icon
3266
Walker & Dunlop
WD
$1.65B
$4K ﹤0.01%
101
XIN
3267
DELISTED
Xinyuan Real Estate
XIN
$4K ﹤0.01%
100
LL
3268
DELISTED
LL Flooring Holdings, Inc.
LL
$4K ﹤0.01%
187
UNVR
3269
DELISTED
Univar Solutions Inc.
UNVR
$4K ﹤0.01%
128
ACOR
3270
DELISTED
Acorda Therapeutics
ACOR
$4K ﹤0.01%
2
MGI
3271
DELISTED
MoneyGram International, Inc. New
MGI
$4K ﹤0.01%
224
CLVS
3272
DELISTED
Clovis Oncology, Inc.
CLVS
$4K ﹤0.01%
+61
New +$3.71K
FLXN
3273
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4K ﹤0.01%
131
BPFH
3274
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$4K ﹤0.01%
222
CRCM
3275
DELISTED
CARE.COM, INC.
CRCM
$4K ﹤0.01%
+300
New +$2.97K

Similar funds

US Bancorp's Q1 2017 Portfolio in Review

As of Q1 2017, US Bancorp held 3,780 positions worth $29.2B, up 5% from $27.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q1 2017 filing shows 179 new, 1,287 increased, 1,288 reduced and 176 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M. The largest sale was Berkshire Hathaway Class A, an estimated $44.4M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • US Bancorp's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M.
  • US Bancorp added most to iShares Core MSCI EAFE ETF in Q1 2017, an estimated $43M increase.
  • US Bancorp's biggest Q1 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $44.4M.
  • US Bancorp fully exited St Jude Medical in Q1 2017, selling an estimated $23.2M.
  • US Bancorp's ten largest holdings make up 23% of its $29.2B portfolio in Q1 2017.
  • US Bancorp opened 179 new positions and closed 176 in Q1 2017.
  • US Bancorp's portfolio value rose 5% quarter-over-quarter to $29.2B.

Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.